A Critical Analysis on Impact of Clinical Pharmacist based Medication Reconciliation Practice among Cancer Patients-A Prospective Interventional Study.
Abstract
Keywords
Full Text:
PDFReferences
Herledan C, Baudouin A, Larbre V, Gahbiche A, Dufay E, Alquier I. Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Support Care Cancer. 2020;28:3557–3569.
Kraus SK, Sen S, Murphy M, Pontiggia L. Impact of a pharmacy technician-centered medication reconciliation program on medication discrepancies and implementation of recommendations. Pharm Pract. 2017;15:901. doi: 10.18549/PharmPract.2017.02.901.
Damlien L, Davidsen N, Nilsen M, Godø A, Moger TA, Viktil KK. Drug safety at admission to emergency department: an innovative model for PRIOritizing patients for MEdication reconciliation (PRIOMER) Eur J Emerg Med. 2017;24:333–339.
Son H, Kim J, Kim C, Ju J, Lee Y, Rhie SJ. Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study. Eur J Hosp Pharm. 2018;25(1):21–25.
Weingart SN, Cleary A, Seger A, Eng TK, Saadeh M, Gross A, et al. Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007;33(12):750–757.
Vega TG-C, Sierra-Sánchez JF, Martínez-Bautista MJ, García-Martín F, Suárez-Carrascosa F, Baena-Cañada JM. Medication reconciliation in oncological patients: a randomized clinical trial. J Manag Care Spec Pharm. 2016;22:734–740.
Duffy AP, Bemben NM, Li J, Trovato J. Facilitating home hospice transitions of care in oncology: evaluation of clinical pharmacists' interventions, hospice program satisfaction, and patient representation rates. Am J Hosp Palliat Care. 2018;35(9):1181–1187. 8. Nguyen PAA, Enwere E, Gautreaux S, Lin H, Tverdek F, Lu M, et al. Impact of a pharmacy-driven transitions-of-care program on postdischarge healthcare utilization at a national comprehensive cancer center. Am J Health Syst Pharm. 2018;75:1386–1393.
Taché SV, Sönnichsen A, Ashcroft DM. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011;45:977–89. 10.1345/aph.1P627.
Azim M, Khan A, Khan TM, et al.. A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan. BMC Health Serv Res 2019;19:583. 10.1186/s12913-019-4420-7.
Dorothy A, Yadesa TM, Atukunda E. Prevalence of medication errors and the associated factors: a prospective observational study among cancer patients at Mbarara Regional Referral Hospital. Cancer Manag Res 2021;13:3739–48. 10.2147/CMAR.S307001.
Baker GR, Norton PG, Flintoft V, et al.. The Canadian adverse events study: the incidence of adverse events among hospitalized patients in Canada. CMAJ 2004;170:1678–86. 10.1503/cmaj.1040498.
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research & Reviews: A Journal of Drug Design & Discovery